For the Culture By The Culture. ISSN: 3064-9331.
Cannabis legalization was sold as the end of the illicit market. Instead, stacked taxes, licensing limits, and local bans created price gaps that allowed underground sales to survive. From California’s cultivation tax to Illinois pricing and Michigan’s price compression, this installment of Cannabis Lie examines how policy design, not the plant, determines who wins and who stays in the shadows.
THE CANNABIS LIE is a reporting series examining how cannabis policy turns shaky assumptions into hard penalties. In THE CANNABIS LIE: Vol. 2, The Fiction of Impairment, THC detection is often treated like proof of impairment, even though blood levels show a weak, inconsistent relationship to functional driving ability. This installment explains why per se THC limits and zero tolerance rules create false certainty, why urine metabolites only show prior exposure, and why real impairment should be demonstrated through behavior and context, not presumed from a lab result.
As 2025 closes, cannabis reform headlines promised progress while delivering performance. Pot Culture Magazine looks back without celebration, without hype, and without illusions. This year did not resolve prohibition or fix power. It revealed who controls the narrative, who benefits from delay, and why cannabis culture keeps surviving without permission.
Federal officials claim cannabis is moving forward, but Schedule III changes nothing that matters. This investigation breaks down what rescheduling actually does, what it deliberately avoids, and why prohibition logic remains intact. Arrests continue. Markets remain conflicted. Reform language replaces reform action. The system shifts labels while preserving control.
Hospitals increasingly diagnose Cannabinoid Hyperemesis Syndrome without testing the cannabis products involved. This investigation examines how cartridges, edibles, and other cannabis materials are excluded from medical evaluation, despite known contamination risks, leaving patients with diagnoses based on symptoms and self reported use rather than verified evidence.
Massachusetts faces a new THC accuracy fight after a law enforcement group claims dispensary labels inflate potency. Testing limits, natural variance, and oversight failures collide as the state struggles to rebuild trust in a system built on imperfect numbers. This feature exposes how the market turned THC into gospel and why the truth was never that simple.
